Modified C-Reactive Protein Selectively Binds to Immunoglobulins

Scandinavian Journal of Immunology

Volumn 76, Issue 1, 2012, Pages 1-10

  Boncler, M ^a   Dudzinska D ^a   Nowak, J ^a   Watala, C ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD16 ANTIGEN; CD32 ANTIGEN; COMPLEMENT COMPONENT C1Q; FIBRINOGEN; FIBRONECTIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY;

ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN ELECTROPHORESIS; PROTEIN IMMOBILIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; C-REACTIVE PROTEIN; COMPLEMENT C1Q; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN; FIBRONECTINS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SERUM ALBUMIN;

EID: 84862242304     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02704.x     Document Type: Article

References (25)

1. Betanzos A, Schnoor M, Severson EA, Liang TW, Parkos CA. Evidence for cross-reactivity of JAM-C antibodies: implications for cellular localization studies. Biol Cell 2009;101:441-53.
2. Virdi AS, Thakur A, Dutt S, Kumar S, Singh P. A sorghum 85kDa heat stress-modulated protein shows calmodulin-binding properties and cross-reactivity to anti-Neurospora crassa Hsp 80 antibodies. FEBS Lett 2009;583:767-70.
3. Kwong LS, Thom M, Sopp P et al. Production and characterization of two monoclonal antibodies to bovine tumour necrosis factor alpha (TNF-alpha) and their cross-reactivity with ovine TNF-alpha. Vet Immunol Immunopathol 2010;135:320-4.
4. Udvarnoki K, Cervenak L, Uray K et al. Antibodies against C-reactive protein cross-react with 60-kilodalton heat shock proteins. Clin Vaccine Immunol 2007;14:335-41.
5. Delgado AV, Alexander SL, McManus AT, Pusateri AE. Antibodies against human cell receptors, CD36, CD41a, and CD62P crossreact with porcine platelets. Cytometry B Clin Cytom 2003;56:62-7.
6. Fortis F, Guerrier L, Areces LB et al. A new approach for the detection and identification of protein impurities using combinatorial solid phase ligand libraries. J Proteome Res 2006;5:2577-85.
7. Smykal-Jankowiak K, Niemir ZI. [Structure and function of complement protein C1q and its role in the development of autoimmune diseases]. Postepy Hig Med Dosw (Online) 2009;63:134-41.
8. Lu JH, Teh BK, Wang L et al. The classical and regulatory functions of C1q in immunity and autoimmunity. Cell Mol Immunol 2008;5:9-21.
9. Ji SR, Wu Y, Potempa LA, Qiu Q, Zhao J. Interactions of C-reactive protein with low-density lipoproteins: implications for an active role of modified C-reactive protein in atherosclerosis. Int J Biochem Cell Biol 2006;38:648-61.
10. Glasgow JE, Colman RW. Fibronectin synthesized by a human hepatoma cell line. Cancer Res 1984;44:3022-8.
11. O'Connell TX, Horita TJ, Kasravi B. Understanding and interpreting serum protein electrophoresis. Am Fam Physician 2005;71:105-12.
12. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
13. Akerman ME, Pilch J, Peters D, Ruoslahti E. Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature. Proc Natl Acad Sci U S A 2005;102:2040-5.
14. McGrath FD, Brouwer MC, Arlaud GJ, Daha MR, Hack CE, Roos A. Evidence that complement protein C1q interacts with C-reactive protein through its globular head region. J Immunol 2006;176:2950-7.
15. Okuda M, Uemura Y, Tatsumi N. Quality control material for plasma fibrinogen test produced from purified human fibrinogen. J Autom Methods Manag Chem 2003;25:79-85.
16. Taylor KE, van den Berg CW. Structural and functional comparison of native pentameric, denatured monomeric and biotinylated C-reactive protein. Immunology 2007;120:404-11.
17. Zhang W, Ewan PW, Lachmann PJ. The paraproteins in systemic capillary leak syndrome. Clin Exp Immunol 1993;93:424-9.
18. Kijanka G, Ipcho S, Baars S et al. Rapid characterization of binding specificity and cross-reactivity of antibodies using recombinant human protein arrays. J Immunol Methods 2009;340:132-7.
19. Dirstine PH, Maccallum DB, Anson JH, Mohammed A. Optimum clinical application of serum protein electrophoresis. Clin Chem 1964;10:853-61.
20. Boehm TK, DeNardin E. Fibrinogen binds IgG antibody and enhances IgG-mediated phagocytosis. Hum Antibodies 2008;17:45-56.
21. Boguslawski G, McGlynn PW, Potempa LA, Filep JG, Labarrere CA. Conduct unbecoming: C-reactive protein interactions with a broad range of protein molecules. J Heart Lung Transplant 2007;26:705-13.
22. Boncler M, Rywaniak J, Sicinska P, Watala C. Effectiveness of modified C-reactive protein in the modulation of platelet function under different experimental conditions. Blood Coagul Fibrinolysis 2011;22:301-9.
23. Khreiss T, Jozsef L, Potempa LA, Filep JG. Opposing effects of C-reactive protein isoforms on shear-induced neutrophil-platelet adhesion and neutrophil aggregation in whole blood. Circulation 2004;110:2713-20.
24. Khreiss T, Jozsef L, Potempa LA, Filep JG. Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation 2004;109:2016-22.
25. Eisenhardt SU, Habersberger J, Murphy A et al. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circ Res 2009;105:128-37.